Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study

• Main Authors: María José Muñoz-Gómez (Author), Pablo Ryan (Author), Marta Quero-Delgado (Author), María Martin-Vicente (Author), Guillermo Cuevas (Author), Jorge Valencia (Author), Eva Jiménez (Author), Natalia Blanca-López (Author), Miguel Ángel Lara-Álvarez (Author), José Ángel Hernández-Rivas (Author), Gerardo Redondo (Author), Vicente Mas (Author), Daniel Sepúlveda-Crespo (Author), Mónica Vázquez (Author), Juan Torres-Macho (Author), Isidoro Martínez (Author), Salvador Resino (Author)
• Format: Book
• Published: Elsevier, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Cancer patients often have weakened immune systems, resulting in a lower response to vaccines, especially those receiving immunosuppressive oncological treatment (OT). We aimed to assess the impact of OT on the humoral and T-cell response to the B.1 lineage and Omicron variant following...